| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | €8,6874 | -0,10% | €155,94M | €5,71K | |
BRR ProCap Financial, Inc. Common Stock | €1,6338 | -6,53% | €155,88M | €818,61K | |
HUMA Humacyte, Inc. Common Stock | €0,56235 | -0,68% | €155,42M | €4,51M | |
HTLM HomesToLife Ltd Ordinary Shares | €1,6865 | -2,04% | €155,19M | €15,54K | |
| €46,9900 | -3,19% | €155,01M | €30,11K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | €14,7044 | -0,65% | €154,86M | €15,47K | |
PAAC Proem Acquisition Corp I Ordinary Shares | €8,7445 | -0,05% | €154,74M | €93,98 | |
BNR Burning Rock Biotech Limited American Depositary Shares | €8,1252 | +1,20% | €154,70M | €1,71K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,8737 | -3,71% | €154,52M | €107,30K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | €8,9509 | +0,00% | €154,16M | €8,79K | |
| €3,2852 | -9,44% | €154,05M | €109,10K | |
ECBK ECB Bancorp, Inc. Common Stock | €17,8315 | +2,22% | €153,86M | €9,37K | |
TNXP Tonix Pharmaceuticals Holding Corp. | €9,3462 | +0,47% | €153,74M | €333,25K | |
| €7,9144 | -2,70% | €153,62M | €216,12K | |
DHF BNY Mellon High Yield Strategies Fund | €2,0928 | -0,73% | €153,34M | €370,05K | |
